Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1875625
Reference Type
Journal Article
Title
Removal of Nickel by Chelating Drugs from the Organs of Nickel Poisoned Rats
Author(s)
Dwivedi, PP; Athar, M; Hasan, SK; Srivastava, RC
Year
1986
Is Peer Reviewed?
Yes
Journal
Chemosphere
ISSN:
0045-6535
EISSN:
1879-1298
Report Number
NIOSH/00165143
Volume
15
Issue
6
Page Numbers
813-821
Abstract
The effect of some polyaminocarboxylic acids on nickel (7440020) removal from body organs was examined. The chelating drugs examined included ethylenediamine-tetraacetic-acid (EDTA), 1,2-cyclohexylenediamine-tetraacetic-acid (CDTA), diethylenetriamine-pentaacetic-acid (DTPA), hydroxyethylenediamine-triacetic-acid (HEDTA), and triethylenetetraamine-hexaacetic acid (TTHA). Male albino-rats were used for the study with 66 percent of them receiving partial hepatectomies and the others receiving sham operations. Single subcutaneous injection of nickel-chloride (7718549) were given to the rats immediately following the operation. Chelating drugs were administered 30 minutes after nickel administration. Partial hepatectomy did not alter the distribution of nickel in rats between the liver, kidney, heart and lung at 72 hours after administration. Nickel burden in all four organs was diminished after administration of the chelating agents, with the kidney showing the greatest reduction. The decrease in nickel content suggests the formation of stable and excretable complexes. A higher degree of efficiency in removing nickel from the organs was obtained with EDTA, CDTA, and HEDTA. The suggestion was made that these agents might be useful in medical treatment in early nickel poisoning.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity